Procter & Gamble Health Ltd - 500126 - Shareholding for the Period Ended June 30, 2020
Procter & Gamble Health Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click here20-07-2020
20-07-2020
Procter & Gamble Health Ltd - 500126 - Disclosure Of Fund Raising By Issuance Of Debt Securities By Large Entities
We refer to the SEBI Circular No SEBI/HO/DDHS/ CIR/ P/ 2018/144 dated November 26, 2018 with respect to fund raising by issuance of Debt Securities by large entities and disclosures thereof by such large entities. In this regard, we wish to inform you that the Company does not fall under the criteria as specified in para 2.2 of the said SEBI Circular. Hence, our Company does not classify as a 'Large Corporate' under the framework provided in the above mentioned circular. Kindly take the above on record and acknowledge the receipt.15-07-2020
Procter & Gamble Health Ltd - 500126 - Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0101 Name of the Signatory :- Preeti Bishnoi Designation :- Company Secretary and Compliance Officer13-07-2020
Procter & Gamble Health Ltd - 500126 - Closure of Trading Window
We would like to inform you that the Trading Window of the Company shall remain closed for Directors and designated employees from July 1, 2020 until 48 hours from the publication of the unaudited financial results. Kindly take the same on record.30-06-2020
Procter & Gamble Health Ltd - 500126 - Appointment of Company Secretary and Compliance Officer
We would like to inform you that Ms. Preeti Bishnoi has been appointed as Company Secretary of the Company effective June 1, 2020. In this respect, please find below brief profile of Ms. Bishnoi: Ms. Preeti Bishnoi, is qualified Company Secretary and who has also done her Masters in Law from London and Bachelors of Law from Bangalore. She has about 11 years of work experience in the areas of Business Advisory, Compliance, Competition Law, Advertisement Laws, Digital & Privacy Laws and Dispute Resolution. In her career span of 11 years, she has led complex legal projects having exposure to numerous laws & regulations. Having worked in P&G;''s Regional Head Quarters in Geneva, she has gained valuable experience in Legal and Business areas. Kindly take the above on record and acknowledge the receipt.29-05-2020
Procter & Gamble Health Ltd - 500126 - Outcome Of Board Meeting
We are pleased to inform you that at the meeting of the Board of Directors of the Company held today, the Unaudited Financial Results for the quarter ended March 31, 2020 were approved. We are enclosing herewith the following: a. Unaudited Financial Results for the quarter ended March 31, 2020; and b. Limited Review Report in respect of the Unaudited Financial Results for the quarter ended March 31, 2020 furnished by Statutory Auditors of the Company Kindly take the same on record and oblige.29-05-2020
Procter & Gamble Health Ltd - 500126 - Unaudited Financial Results - March 31, 2020
We are pleased to inform you that at the meeting of the Board of Directors of the Company held today, the Unaudited Financial Results for the quarter ended March 31, 2020 were approved. We are enclosing herewith the following: a. Unaudited Financial Results for the quarter ended March 31, 2020; and b. Limited Review Report in respect of the Unaudited Financial Results for the quarter ended March 31, 2020 furnished by Statutory Auditors of the Company Kindly take the same on record and oblige.29-05-2020
Merck to buy Austrian vaccine maker as it jumps into COVID-19 race
It also announced a partnership with privately held Ridgeback Biotherapeutics to develop an experimental oral antiviral drug against COVID-1927-05-2020
Procter & Gamble Health Ltd - 500126 - Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results For The Quarter Ended March 31, 2020.
Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2020 ,inter alia, to consider and approve the unaudited financial results for the quarter ended March 31, 2020.22-05-2020
Procter & Gamble Health Ltd - 500126 - Approval From Registrar Of Companies, Ministry Of Corporate Affairs For Extension Of Time For Conducting The Annual General Meeting Of The Company For Financial Year 2019-20
We would like to inform you that, the Company has received the approval from the office of the Registrar of Companies, Ministry of Corporate Affairs, Mumbai vide its order dated April 28, 2020 for extension of time by a period of three months i.e. upto November 30, 2020 for conducting the Annual General Meeting of the Company for Financial Year 2019-20. A copy of the said order dated April 28, 2020 is enclosed. We request you to take the same on record.29-04-2020